The purpose of the study is to determine whether NB002, 0.25%, and 0.5% are safe and effective in the treatment of distal subungual onychomycosis of the toenail.
The purpose of the study is to determine whether NB002, 0.25%, and 0.5% are safe and effective in the treatment of distal subungual onychomycosis of the toenail.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
443
International Dermatology Research
Miami, Florida, United States
Planimetry assessment of the target great toenail
Time frame: Week 24
Rate of complete cure
Time frame: Week 46
Rate of therapeutic success
Time frame: Week 46
Investigator's visual assessment of length of new unaffected nail
The presence/absence of DSO on all toenails
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Northwest Clinical Trial
Boise, Idaho, United States
Welborne Clinic
Evansville, Indiana, United States
Michigan Center for Research Corp.
Clinton Township, Michigan, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
Academic Dermatology Associates
Albuquerque, New Mexico, United States
Oregon Dermatology and Research Center
Portland, Oregon, United States
Oregon Medical Research Center, PC
Portland, Oregon, United States
DermResearch Inc.
Austin, Texas, United States
J & S Studies, Inc.
Bryan, Texas, United States
...and 14 more locations